Publications by authors named "M Koeppen"

Article Synopsis
  • Sepsis and septic shock are serious conditions linked to infections and can lead to high mortality rates; this article reviews extracorporeal procedures for their treatment.
  • Various treatments like HVHF, VHVHF, HCO, and Polymyxin B hemoperfusion aim to remove inflammatory substances but lack clear evidence for improving patient survival.
  • Despite showing promise in initial studies, risks such as thrombosis and protein loss remain, and further research is needed to establish the safety and efficacy of these treatments for sepsis.
View Article and Find Full Text PDF

Background: Risk stratification and outcome prediction are crucial for intensive care resource planning. In addressing the large data sets of intensive care unit (ICU) patients, we employed the Explainable Boosting Machine (EBM), a novel machine learning model, to identify determinants of acute kidney injury (AKI) in these patients. AKI significantly impacts outcomes in the critically ill.

View Article and Find Full Text PDF

Pulmonary defense mechanisms are critical for host integrity during pneumonia and sepsis. This defense is fundamentally dependent on the activation of neutrophils during the innate immune response. Recent work has shown that semaphorin 7A (Sema7A) holds significant impact on platelet function, yet its role on neutrophil function within the lung is not well understood.

View Article and Find Full Text PDF

Background: Veno-arterial extracorporeal membrane oxygenation (vaECMO) removal reflects a critical moment and factors of adverse outcomes are incompletely understood. Thus, we studied various patient-related factors during vaECMO removal to determine their association with outcomes.

Methods: A total of 58 patients from a university hospital were included retrospectively.

View Article and Find Full Text PDF

Background: Venovenous extracorporeal membrane oxygenation (vvECMO) is used to treat hypoxia in patients with severe acute respiratory distress syndrome (ARDS). Nevertheless, uncertainty exists regarding the optimal timing of initiation of vvECMO therapy. We aimed to investigate the association between number of days of invasive mechanical ventilation (IMV) prior to vvECMO implantation and mortality.

View Article and Find Full Text PDF